Since its establishment in October 1998, Shin Jin Medics Inc. R&D Laboratories for Reagent has strived to research and develop diagnostic products in order to be a leader and a topnotch in the diagnostic reagent- related field.
From the beginning, it has performed a variety of research activities and possessed Hepatitis, Tumor marker, Triple marker, Infectious disease, Hormone and the like. It has brought satisfactory results by stretching list of products and improving performance as a result of continuous studies.
First, it cultivats RACER method to maximize product efficiency and secures technology to produce most test results within one hour. Consequently, as the industry's first, it is successful to reduce examination time less than one hour required for CA19-9 IRMA and other tumor markers.
Second, through sincere research and development, it accomplished to develop and produce Ultra-sensitive HBsAg, Ultra-sensitive PSA for the first commercial use of RIA kits. It also made a success of TSH IRMA, the 3rd generation to detect TSH, thyroid marker, up to 0.005 ng/ml.
Diagnostic Reagent Development Institute attached to Shinjin Medics Inc. is composed of R&D, Manufacture and QC and does everything in its power to produce the highest quality's products with close cooperation between relevant divisions.
As a result, it acquired ISO9001 approved by BSI (British Standard institution) in Feb of 2001 and CE Mark, European Notified Body's Approval by reason of Quality Management.
For decades to come, Diagnostic Reagent Development Institute attached to Shinjin Medics Inc. will stick to our last by developing and manufacturing first-class products.